chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakness generalised; Dizziness aggravated; tiredness; fever; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (Weakness generalised), DIZZINESS (Dizziness aggravated), FATIGUE (tiredness) and PYREXIA ( fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (tiredness) and PYREXIA ( fever). On 24-Feb-2021, the patient experienced ASTHENIA (Weakness generalised) and DIZZINESS (Dizziness aggravated). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. On 21-Feb-2021, FATIGUE (tiredness) and PYREXIA ( fever) had resolved. At the time of the report, ASTHENIA (Weakness generalised) and DIZZINESS (Dizziness aggravated) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to emergency visit. Patient was not taking any other concomitant medications. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to MOD-2021-039630 (Patient Link).
*Fever, initially (my baseline is 97.5) of 99.2 on evening of day of injection 1/11/21 ,  evening of 1/12/21 was 100.9 , fever morning of 1/13/21  is 100.7. Fever being managed with Tylenol. * Mild transient dizziness. * Moderate pain and swelling at injection site. *SEVERE fatigue. *Severe muscle and joint pain over entire body.
erythema, tenderness around vax site devel next day;dx cellulitis;rx warm compresses, course dicloxacillin;
Post Menopausal full menstration days 21-28 after first dose; This is a spontaneous report from a Non-contactable consumer (Patient reported for herself).  A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot Number: Unknown), via unspecified route of administration, in left arm on 31Mar2021 (at the age of 53-year-old) as a dose 1, single for COVID-19 immunization. The patient medical history and concomitant medication was not reported. The patient had not taken other vaccine in four weeks and no other medication in two weeks. Patient had no known allergies and no other medical history. Patient had no COVID prior to vaccination and not tested post COVID vaccination. On19May2021 the patient experienced post-menopausal full menstruation days 21-28 after first dose. Patient does not receive any treatment for the reported event. Outcome for the reported event was unknown. No follow-up attempts are possible: information about lot/batch number/expiry date cannot be obtained.
Fever, chest pain, cough, headache, chest tightness, shortness of air and fatigue. Symptoms began about 5pm on 1/6/21. Came to the emergency room on 1-7-21. Negative for COVID per PCR test.
2 hours after taking the vaccine, burning and red eyes, body pain, increased butt pain and leg pain, headache , feeling warmth but no fever. Arm sore, had injection in left arm, had left neck and left upper back pain.
My dad had AFIB. My smart watch had started indicating that I was experiencing AFIB. It was not constant AFIB until mid-December.  It feels like thumbing and bumping, not much at all. My cardiologist says I'm non-symptomatic. I have seen my cardiologist who has been waiting on this to happen due to my father condition. I am admitting that this is not vaccine related.
one eye is red like it has vessels like broken or bleeding in there; This is a spontaneous report received from a contactable consumer (patient). A 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 02Apr2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was feeling ok and everything, but one eye was red like it had vessels like broken or bleeding in there on 02Apr2021, she said it didn't hurt. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Patient presented to the pharmacy to receive her second dose of Moderna covid vaccine.  After getting the vaccine, she went back to sit down with her father who had accompanied her because of previous episodes when receiving injections.  After just a few minutes, the patient became pale, began to sweat and passed out briefly.  She did not fall or hit anything.  We got a cold pack and applied to the back of her neck and got her some water.  After about 15 minutes, she began talking normally and was starting to feel better.  She stayed for another 15 -30 minutes to make sure she was feeling ok.  One of our technicians walked to the vehicle with her and her father to make sure she was still ok when she got to the car.  We called and checked on her this evening aroung 6pm and she was feeling much better.
A day after vaccination, my daughter started experiencing random involuntary jerking.  Mainly her left arm.  I remembered this from the last Hep B dose and hoped it would resolve the same. It lasted about 2 weeks.  I would see it here and there after but not very often.
Subjective tongue swelling, started 30 minutes later, lasted a few hours. Recurred iwth second dose.
This initial non-serious spontaneous case, received from a pharmacist on 28-Aug-2017. Patient's medical history and concomitant medications were not reported. On 28-Aug-2017, the patient received FLUCELVAX QIV (batch number: 195123, expiry date: Mar-2018) (not sure whether the patient received FLUCELVAX or FLUAD, MF59, batch number: 2J2EC (as reported), expiry date: May-2018) (dose: 0.5 ml, route of administration and anatomical location was not reported). It was reported that FLUAD (Influenza Vaccine, Adjuvanted) is to be stored protected from light and refrigerated between 36 degrees F and 46 F (2 degrees C and 8 degrees C) as stated in the approved product label and must not be freeze. It was reported by the pharmacist that, the refrigerator reached 8F over the night and wanted to know, if they can still administer the vaccines (FLUCELVAX and FLUAD) characterized by incorrect product storage. The pharmacist thought that, the vaccine might have been administered to a single patient characterized by drug administration error, but does not want to provide the information because she was not sure. It was stated by the pharmacist that, even though the vaccines were subjected to a temperature of 8F for 12 hours (temperature excursion below recommended temperature), the vaccines were not frozen. The outcome of the events were not reported.
Fever 103; First dose of Vaxelis scheduled at 1.5 years.; This case was retrieve during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2422612-1. The original narrative from the sender is the following:  Fever 103, given Tylenol & Advil at Hospital.  The reporter did not provide an assessment of causal relationship between Vaxelis and the reported event "Fever 103". Due to the nature of the event the causal relationship between Vaxelis and First dose of Vaxelis scheduled at 1.5 years was not applicable.  No further information is expected.
Felt like don't have any strength in it; Entire left arm felt numb for a whole day, so as left leg; Soreness on left arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 01May2021 at 11:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical and drug history.  The patient did not receive any other medications within 2 weeks of vaccination: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient took the vaccination on Saturday 01May2021 and everything was fine other than soreness on left arm. On 03May2021, day 3 Monday entire left arm felt numb for a whole day, so as left leg and felt like don't have any strength in it. The patient forced herself to continue normal routine. Patient used a hot water bag as treatment to stimulate muscles and went away by day 4. The clinical outcome of the events soreness on left arm and entire left arm felt numb for a whole day, so as left leg was recovered on an unknown date in May2021 and felt like don't have any strength in it was recovered on 04May2021.   No follow-up attempts are needed. No further information is expected.
Patient received vaccine on Wednesday, February 10 and had severe vomiting and diarrhea starting 5 days later on 2/15.  I advised patient to seek medical attention if symptoms persist due to increased blood pressure and possible dehydration
Pt arm was swollen to elbow, went to  doctors office and confirmed infection had occurred. Pt took a course of antibiotics and it has now resolved
This spontaneous report was received from a pharmacist refers to a 60 year old female patient. On 01-FEB-2014, the patient was vaccinated with expired ZOSTAVAX lot # H013021 (Expiry: 09-OCT-2013), 0.65 ml, subcutaneous in the left arm. No adverse effects reported. No further details provided. Additional information has been requested.
first and second dose, experiencing internal Shingles/Suspected vaccination failure; Internal shingles; Nerve pain from jaw to ear; Burning from jaw to ear; receiving third dose of Shingrix; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   In August 2022, the patient received the 3rd dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. In August 2022, unknown after receiving Shingrix and not applicable after receiving Shingrix and Shingrix, the patient experienced extra dose administered. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, post herpetic neuralgia and burning sensation. On an unknown date, the outcome of the vaccination failure and extra dose administered were unknown and the outcome of the shingles was recovered/resolved and the outcome of the post herpetic neuralgia and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, post herpetic neuralgia and burning sensation to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 12-OCT-2022 Reporter's Comment: The reporter was a patient. The reporter reported that the patient received first and second dose of Shingrix approximately three years ago prior to the reporting. The reporter stated that the patient recently experienced a case of internal shingles, resulting in healthcare professional who was unaware of patient was previously fully vaccinated, he recommended to receive Shingrix vaccine, once Shingles resolved. The patient received 3rd dose of Shingrix vaccine 2 months prior to the reporting. The reporter reported that the internal shingles consisted of burning and nerve pain from the jaw to the ear. The patient advised their shingles had resolved but they continue to experience nerve pain and burning from their jaw to the ear. The reporter did not consent to follow up. Additional supportive information: This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding shingles were unknown at the time of reporting. The patient received extra dose of Shingrix in error, which led to extra dose administered.
Moderna/Dose number 4; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Jan2021 at 10:30 as dose 1, single (Lot number: EL3247), in left arm, on 20Feb2021 at 15:00 as dose 2, single (Lot number: EN6201), in right arm and on 31Dec2021 at 15:00 as dose 3 (booster), single (Lot number: FF8841) at the age of 70 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 01Sep2022 at 09:45 as dose 4 (booster), single (Lot number: 054A22A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Mitro Valve prolapse" (unspecified if ongoing), notes: Mitro Valve prolapse; "Known allergies: Opioids" (unspecified if ongoing). Concomitant medication(s) included: ESTRADIOL, start date: 17Jun2020. Past drug history included: Macrobid, reaction(s): "Known allergies: Macrobid", notes: Macrobid. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 01Sep2022 at 09:45, outcome "unknown", described as "Moderna/Dose number 4". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Dec2022) Negative, notes: Tested negative on the 1st day and 3rd day after completing the Paxlovid; (30Dec2022) Negative, notes: Tested negative on the 1st day and 3rd day after completing the Paxlovid; (02Jan2023) Positive, notes: I tested and was positive for COVID once again. Therapeutic measures were taken as a result of vaccination failure, covid-19. Patient was treated with Paxlovid from 23Dec2022 to 28Dec2022. Patient took other medication in 2 weeks.
Fever. Fever increased high fever 103.  overnight. GI - nausea, diarrhea. Malaise. Very sore at injection site. Body aches all over. Fever lasted 20 hours. Diarrhea lasted 20 hours.
24-48 hours of intense joint pain- exacerbated the pain felt in joints affected by psoriatic arthritis, nausea, feeling of being overheated but no temperature.
I did and got the Flu anyway; Initial information was received on 01-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves unknown age and unknown gender patient who stated that, "i did and got the flu anyway" while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number: not reported) via unknown route in unknown administration site (strength, dose, frequency: unknown). for prophylactic vaccination.  On an unknown date the patient developed a non-serious event of "i did and got the flu anyway" (influenza) (latency: unknown) following the administration of influenza vaccine.  Action taken with influenza vaccine was unknown.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Patient was complaining of severe fatigue on the day following vaccination. She did not feel it was necessary to visit a doctors office until 10/06/2021 because the fatigue was still severe as well as accompanying body aches and mild SOB. Labs were ordered and Hgb came back at 7.8 g/dL; Hct 30.3%, and platelets 500 thousand/uL.
Pancreatic insufficiency - on June 8th and for  the next six consecutive days, I could not digest any fat.  I had severe diarrhea, even running down my legs.  I had steathorrea with the telltail pungent odor, light color feces and particles of fat micelles floating on the water in the toilet.  I had to remove fat from my diet completely for 2.5 days to resolve the diarrhea.  Lab work including a fecal fat analysis was completed.  Results revealed all lab values WNL except my lipase level (10) was at the very lowest end of the normal spectrum (9 - 60) and the fecal fat analysis found the results to be well above normal levels at which point my MD confirmed pancreatic insufficiency.  There was also tenderness to my pancreas during physical examination.
Narrative: Patient received 2nd dose of Moderna COVID vaccine on 12/15/2021. About 10 minutes after receiving vaccine, reported feeling flushed with her face feeling hot, along with having dizziness, nausea, and abdominal cramping. Diphenhydramine 50 mg given for moderate reaction. Patient reports improved symptoms afterward and was advised to seek ER care for worsening of symptoms afterward and was advised to seek ER care for worsening of symptoms.
SEVERE SWELLING, PAIN AND REDNESS AT SITE OF INJECTION HEADACHE AND NAUSEA FEVER
Patient was admitted to the hospital on 9/14/21 with hypoxia due to pneumonia due to COVID-19.
Mom did not call us when she noticed the swelling the next day. Redness resolved over the next 48 hours but lump has persisted. She mentioned it to us when she came on 5/1/02 for a visit.
Moderate pain in her arm; This is a spontaneous report from a contactable consumer (patient herself) via a medical information team. An 80-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 24May2021 (at the age of 80-year-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant mediations were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. It was reported that, caller, female, aged 80, received her second dose of the Pfizer BioNTech Covid 19 vaccine yesterday on 24May2021. She was now (on an unspecified date in May2021) having moderate pain in her arm and was wondering how long it might last. The event was considered as non-serious by the consumer. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This case was reported by a physician via sales rep and described the occurrence of syncope in a 18-year-old female patient who received BEXSERO. Concomitant products included MENACTRA. On 29th March 2017 10:00, the patient received the 1st dose of BEXSERO. On 29th March 2017 12:00, 2 hrs after receiving BEXSERO, the patient experienced syncope, feeling cold, clamminess, dizziness and tremor. On 29th March 2017, the outcome of the syncope was recovering/resolving. On an unknown date, the outcome of the feeling cold, clamminess, dizziness and tremor to be related to BEXSERO. Additional details were reported as follows: The patient received BEXSERO and MENACTRA one in each arm, location of each vaccine was not reported. The patient returned to school at approximately 12 noon reported feeling cold, clammy, dizzy and shaky. The patient was referred to the school nurse and returned to her physician's office. On 29th March 2017, elevated blood pressure was noted at the physician office. The patient was sent home with family and noted to be a little shaky at the time of discharge. No additional treatment was noted. The lot numbers and expiration dates of vaccines were not reported. No addition treatment was reported.
5:30pm sitting; felt like "hard to get breath", then developed transient chest pain; then itchy sensation all over body which persisted until about 10pm. Upon awakening next day, symptoms gone. Did call local urgent care facility but did not report for evaluation/treatment.
I had a urinary tract infection that started on Wednesday November 9, 2022. I had burning and inability to void and pelvic pain. I also had a low-grade fever of about 101.0. I called my doctor who put me on amoxicillin and the symptoms dissolved. However, the headache kicked in on Friday November 11, 2022, and has continued to date. I have been using naproxen which really is not doing anything much for, but it slowly seems like its getting better. I have an appointment scheduled for additional treatment. I do have a history of UTI infections.
At 24 hours post-vaccination, I experienced Dizziness. Nausea. Increased Appetite. Muscle aches/pain. Then Fainted and was out for a few minutes. Then woke up on my own. Still experiencing fatigue and some nausea/dizziness and mild diarrhea. Did not get transported to hospital or recieve medical care.
Itchy painful raised rash on arm.; Painful swollen glands around neck and clavicle.; Malaise; Itchy painful raised rash on arm.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the left arm on 04May2021 at 12:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, kidney disease and COVID-19. The patient had no known allergies to medications, food, or other products. The patient received unspecified concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176)  via an unspecified route of administration in the left arm on 11Mar2021 at 15:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 06:00, the patient experienced itchy painful raised rash on arm that progressively became larger over 48 hours, painful swollen glands around neck and clavicle and malaise. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itchy painful raised rash on arm that progressively became larger over 48 hours, painful swollen glands around neck and clavicle and malaise was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse concerning a pt who was vaccinated with varicella vaccine. Subsequently the pt experienced hives. The nurse stated that she had spoken to the physicians in the practice and they did not feel that the hives were related to the pt's vaccination with varicella vaccine, although she was not sure. Additional info has been requested.